Diabetes
Conditions
Keywords
Neuropathies laser and magnetic therapy
Brief summary
This study are to: * Evaluate effect of magnetic therapy on peripheral neuropathy in diabetic patients. * Evaluate effect of laser therapy on peripheral neuropathy in diabetic patients. * Compare effects of magnetic therapy with that of laser therapy on peripheral neuropathy in diabetic patients.
Detailed description
Sixty- five male and female diabetic patients with peripheral neuropathy will be selected to participate in this study. They will be equally divided into two groups Group-I: Twenty five patient with diabetic peripheral neuropathy will be exposed to low intensity pulsed magnetic therapy Group-II: Twenty five patients with diabetic peripheral neuropathy will be exposed for 24 treatment sessions of laser therapy Group-III 15 patient received only medical treatment
Interventions
DEVICEMagnetic therapy
low intensity pulsed magnetic therapy with a frequency of 200 Hertz and intensity of 50 Gauss . Magnetic device will be applied on each patient from a comfortable supine lying position. After the connection of appliance to electrical supply, the actions of PEMF will be directed and adjusted over lumbar spine, hip regions and calf muscles of both lower limbs.
DEVICElaser therapy
laser therapy of Helium neon infrared laser (850 nano-meter) was used in continuous wave mode from a comfortable prone lying position on the whole plantar surface of the foot and the lumbo-sacral area by four points, and two points laterally to the spine.
DRUGOnly medical treatment
Fifteen patients with diabetic peripheral neuropathy were treated with antidiabtic drugs and lyrica 150 milligram daily
Sponsors
Imam Abdulrahman Bin Faisal University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
By randomization of participants recruitment
Eligibility
Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* All diabetic patients with peripheral neuropathy will be selected to participate in this study. * Their age ranges from 35 to 65 years old. * All patients under medical control (optimal blood glucose). such as analgesic medications (e.g. opiates, anti-depressants, anticonvulsants and diabetic drugs to control blood glucose).
Exclusion criteria
* Patients have DPN due to other causes than diabetes * Ulcers in either foot * Lack of blood sugar control * Other nervous system impairments * Visual problems * Unstable medical conditions * Pregnancy * Metallic implants * Alcohol or drug abuse.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Motor and sensory conduction velocity of the lower limb nerves | 30-45 minutes | it is used for measuring motor and sensory conduction velocity: For this purpose nerve conduction studies (NCSs) will be performed for all patients including evaluation of bilateral peroneal and tibia motor nerves and sural sensory nerves (Asad 2009). Patients with NCV from 33-48m /sec will be recruited in this study (Pericz and Cvetkovic 2006 , and Graak 2009). All measurement will be done at stander room temperature of 25 c. The skin temperature of the leg was maintained at 37ᴄ. (Asad et al 2009). |
Outcome results
None listed